Loading patent…
AssigneeThe Government of the U.S.A. as represented by the Secretary of the Dept. of Health & Human Services
InventorsBernard Wolff, Jonas M. Winchell, Maureen Diaz
Estimating the term…
Disclosed herein are methods for detecting presence of one or more of Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, Toxoplasma gondii, Moraxella catarrhalis, Escherichia coli, Shigella, Staphylococcus aureus, Pneumocystis jirovecii, Chlamydia trachomatis, Ureaplasma urealyticum, Ureaplasma parvum, Ureaplasma spp., Bartonella spp., Streptococcus agalactiae, and Neisseria meningitidis nucleic acids in a sample, such as a biological sample obtained from a subject, or an environmental sample. This disclosure also provides probes, primers, and kits for detecting one or more of Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, Toxoplasma gondii, Moraxella catarrhalis, Escherichia coli, Shigella, Staphylococcus aureus, Pneumocystis jirovecii, Chlamydia trachomatis, Ureaplasma urealyticum, Ureaplasma parvum, Ureaplasma spp., Bartonella spp., Streptococcus agalactiae, and Neisseria meningitidis in a sample.
A method for detecting presence of a pathogen selected from the group consisting of Pseudomonas aeruginosa, Pneumocystis jirovecii, Bartonella spp., Acinetobacter baumannii, Klebsiella pneumoniae, Toxoplasma gondii, Moraxella catarrhalis, Escherichia coli, Shigella, Staphylococcus aureus, Chlamydia trachomatis, Ureaplasma urealyticum, Ureaplasma parvum, Ureaplasma spp., Streptococcus agalactiae, and a combination of two or more thereof in a sample, comprising:
3-29. (canceled)
35-47. (canceled)
An isolated nucleic acid probe 20 to 40 nucleotides in length comprising a nucleic acid sequence selected from the group consisting of SEQ ID NOs:
An isolated nucleic acid primer 10 to 40 nucleotides in length comprising a nucleic acid sequence selected from the group consisting of SEQ ID NOs:
Dependencies are inferred from the claim text.